1. Home
  2. LOOP vs MAIA Comparison

LOOP vs MAIA Comparison

Compare LOOP & MAIA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Loop Industries Inc.

LOOP

Loop Industries Inc.

HOLD

Current Price

$1.30

Market Cap

62.8M

Sector

Industrials

ML Signal

HOLD

Logo MAIA Biotechnology Inc.

MAIA

MAIA Biotechnology Inc.

HOLD

Current Price

$1.50

Market Cap

89.7M

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
LOOP
MAIA
Founded
2010
2018
Country
Canada
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
62.8M
89.7M
IPO Year
2010
2022

Fundamental Metrics

Financial Performance
Metric
LOOP
MAIA
Price
$1.30
$1.50
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
42.5K
1.1M
Earning Date
04-27-2026
01-01-0001
Dividend Yield
N/A
N/A
EPS Growth
27.27
29.53
EPS
N/A
N/A
Revenue
$10,889,000.00
N/A
Revenue This Year
N/A
N/A
Revenue Next Year
$174.82
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7016.99
N/A
52 Week Low
$0.88
$0.87
52 Week High
$2.29
$3.19

Technical Indicators

Market Signals
Indicator
LOOP
MAIA
Relative Strength Index (RSI) 50.60 37.65
Support Level $1.17 $1.44
Resistance Level $1.37 $1.52
Average True Range (ATR) 0.07 0.12
MACD -0.01 -0.03
Stochastic Oscillator 39.30 10.95

Price Performance

Historical Comparison
LOOP
MAIA

About LOOP Loop Industries Inc.

Loop Industries Inc. is a technology and licensing company whose mission is to accelerate the world's shift toward sustainable plastic and away from dependence on fossil fuels. The company owns patented and proprietary technology that depolymerizes no and low value waste PET plastic and polyester fiber, including plastic bottles and packaging, carpet and polyester textile of any color, transparency or condition, and even ocean plastics that have been degraded by the sun and salt, to its base building blocks.

About MAIA MAIA Biotechnology Inc.

MAIA Biotechnology Inc is a clinical-stage biopharmaceutical company developing targeted immunotherapies for cancer. THIO (6-thio-dG or 6-thio-2 '-deoxyguanosine), its lead asset, is an investigational dual mechanism of action drug candidate incorporating telomere targeting and immunogenicity. Patients with advanced NSCLC will be treated first with THIO followed a few days later by the immune checkpoint inhibitor Libtayo (cemiplimab), manufactured and commercialized by Regeneron.

Share on Social Networks: